- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sitagliptin (MK0431)
Total 904 results
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Ono Pharmaceutical Co. LtdCompletedType 2 Diabetes MellitusJapan
-
Merck Sharp & Dohme LLCCompleted
-
TakedaCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Istanbul UniversityNestléCompleted
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Japan, Czechia, Hungary, Poland, Spain
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2
-
The University of Texas Health Science Center at...Completed
-
Amsterdam UMC, location VUmcCompletedDiabetes Mellitus | Steroid Diabetes | Glucocorticoid-induced Diabetes | Beta-cell FunctionNetherlands
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
David D'Alessio, M.D.Merck Sharp & Dohme LLCCompleted
-
Lund UniversityCompleted
-
TakedaTerminatedDiabetes Mellitus, Type 2United States, Ukraine, Poland, Malaysia, Canada, Peru, Philippines, Hungary, Russian Federation, South Africa, Argentina, Croatia, Thailand
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
University of ArkansasUniversity Hospital, Geneva; Université de MontréalTerminatedHepatic Encephalopathy | Cirrhosis | Refractory Ascites | Hepatic HydrothoraxUnited States, Canada, Switzerland
-
Merck Sharp & Dohme LLCBristol-Myers SquibbTerminatedType 2 Diabetes Mellitus
-
Shahid Beheshti University of Medical SciencesRecruitingPolycystic Ovary Syndrome | Infertility | ARTIran, Islamic Republic of
-
University College DublinCompletedType 2 Diabetes Mellitus | PsoriasisIreland
-
Merck Sharp & Dohme LLCCompleted
-
Khoo Teck Puat HospitalCompletedType II Diabetes in Subjects BMI 27 to 32Singapore
-
Genuine Research Center, EgyptEva PharmaCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTaiwan, Korea, Republic of, South Africa, Hong Kong, Brazil, China, Ukraine
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)Germany
-
GWT-TUD GmbHTerminatedDiabetes Mellitus Type 2Germany
-
Boehringer IngelheimCompleted
-
Bio-innova Co., LtdNot yet recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Amsterdam UMC, location VUmcEU FP7: SAFEGUARD consortiumCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, Mexico, Germany, Greece, Argentina, India, Australia
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2United States, Puerto Rico, Germany, United Kingdom, Austria
-
Sadat City UniversityBeni-Suef UniversityCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompleted
-
SanofiCompletedType 2 Diabetes MellitusBrazil, Peru, United States, Australia, Canada, Chile, Germany, Guatemala, Mexico, Poland, Romania, Russian Federation, Ukraine
-
Bio-innova Co., LtdNot yet recruiting
-
The Catholic University of KoreaBayerCompletedType 2 Diabetes MellitusKorea, Republic of
-
Emory UniversityMerck Sharp & Dohme LLC; University of Michigan; Temple University; Ohio UniversityCompleted
-
Seoul National University HospitalCompletedDiabetes MellitusKorea, Republic of
-
Sheba Medical CenterCompletedDiabetes Mellitus Type 2Israel
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States